<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Armenia</style></author><author><style face="normal" font="default" size="100%">Dita Permatasari</style></author><author><style face="normal" font="default" size="100%">Lathifah Putri Sinamar</style></author><author><style face="normal" font="default" size="100%">Keke Estera</style></author><author><style face="normal" font="default" size="100%">Almahdy Ahmadin</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The Impact of Sub Acute Administration of Purified Gambier (Uncaria gambir Roxb.) to The Liver and Kidney Functions and its Reversibility on Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">ALP</style></keyword><keyword><style  face="normal" font="default" size="100%">ALT</style></keyword><keyword><style  face="normal" font="default" size="100%">CrCl</style></keyword><keyword><style  face="normal" font="default" size="100%">Liver function</style></keyword><keyword><style  face="normal" font="default" size="100%">Purified gambier</style></keyword><keyword><style  face="normal" font="default" size="100%">Renal function</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">January 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">44-51</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; The impact of sub-acute administration of purified gambier (&lt;em&gt;Uncaria gambir &lt;/em&gt;Roxb.) to the liver and kidney function and its reversibility had been studied on rats. &lt;strong&gt;Methods: &lt;/strong&gt;Rats at the aged of 2-3 months and the bodyweight of ±250 g were treated with water solution of purified gambier at the dose of 5 mg/kg10 and 20 mg/kg for 7 to 14 consecutive days. Plasma ALP, AST activities, creatinine clearance, liver and kidney ratios were determined on the day 1, 7, 14 one week after the doses stopped. All data on each parameter were analyzed using two-way ANOVA followed by Duncan's multiple T-test and significance was taken at p&amp;lt;0.05. &lt;strong&gt;Results: &lt;/strong&gt;The results showed that all parameters was not affected significantly (p&amp;gt;0.1), except ALT activity and liver organ ratio decreased significantly (p&amp;lt;0.05). &lt;strong&gt;Conclusion:&lt;/strong&gt; These indicated that purified gambier is relatively non-toxic to the liver and the kidney of the rats at doses of 5-20 mg/kg BW for 14 days.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">44</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Armenia*, Dita Permatasari, Lathifah Putri Sinamar, Keke Estera, Almahdy Ahmadin &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Faculty of Pharmacy, University of Andalas, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Welly Ratwita</style></author><author><style face="normal" font="default" size="100%">Maman Djamaludin</style></author><author><style face="normal" font="default" size="100%">Hindun Sa’adah</style></author><author><style face="normal" font="default" size="100%">Salsabilla Maharani</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Subchronic Toxicity of Ethanol Extract of Bitter Melon PULP (Momordica Charantia L.) on Liver Function and Histopathological Changes in Wistar Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Histopathological changes</style></keyword><keyword><style  face="normal" font="default" size="100%">Liver function</style></keyword><keyword><style  face="normal" font="default" size="100%">Momordica charantia L.</style></keyword><keyword><style  face="normal" font="default" size="100%">Subchronic Toxicity</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">July 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">949-957</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Bitter melon (&lt;em&gt;Momordica charantia &lt;/em&gt;L.) is a plant that used as herbal medicine. It contains bioactive components which have hypoglycemic activity, immunomodulators, cancer chemoprevention, antiviral, antimicrobial, and inhibits oxidative stress and inflammation. The purpose of this study was to assess the degree of liver damage by macroscopic and microscopic examination. The sample consisted of 40 rats divided into 4 groups, Group 1, control group, was only given aquadest and pellets. Group 2-4 were treated with ethanol extract of bitter melon pulp 250 mg/kgbw, 500 mg/kgbw, and 1000 mg/kgbw during 28 days. On the 29&lt;sup&gt;th&lt;/sup&gt; day, the termination was carried out, aspartate and alanin aminotransferase (AST/ALT) being measured, the liver being observed for the macroscopic and microscopic morphology. Kruskal-Wallis test showed there was no significant difference in relative organ weight (p = 0.177), liver macroscopy morphology (p = 0.207). Microscopic observation for liver fibrosis using Metavir scoring system showed highest mean liver fibrosis score in dose 1000 mg/kgbw. Kruskal-Wallis test for microscopic changes showed significantly difference in male rats (p = 0.001) and female rats (p = 0.002). Based on these study, we conclude that ethanol extract of bitter melon pulp at a dose of 250 mg/kgbw, 500 mg/kgbw, and 1000 mg/kgbw affect liver function significantly. But there’s no subchronic toxicity effect on relative organ weight and macroscopic changes in liver morphology. Otherwise there was subchronic toxicity effect on changes in the microscopic structure of the liver characterized by the formation of fibrosis in the liver portal triad of experimental animals.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">949</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Welly Ratwita&lt;sup&gt;1,&lt;/sup&gt;*, Maman Djamaludin&lt;sup&gt;1&lt;/sup&gt;, Hindun Sa’adah&lt;sup&gt;2&lt;/sup&gt;, Salsabilla Maharani&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Departement of Pharmacology Faculty of Medicine Jenderal Achmad Yani University, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Departement of Anatomy Faculty of Medicine Jenderal Achmad Yani University, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Medical Study Program Faculty of Medicine Jenderal Achmad Yani University, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Yori Yuliandra</style></author><author><style face="normal" font="default" size="100%">Armenia Armenia</style></author><author><style face="normal" font="default" size="100%">Rahmad Arief</style></author><author><style face="normal" font="default" size="100%">Mifta Hul Jannah</style></author><author><style face="normal" font="default" size="100%">Helmi Arifin</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Reversible Hepatotoxicity of Cassytha filiformis Extract: Experimental Study on Liver Function and Propofol-Induced Sleep in Mice</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Cassytha filiformis</style></keyword><keyword><style  face="normal" font="default" size="100%">Liver function</style></keyword><keyword><style  face="normal" font="default" size="100%">Propofol</style></keyword><keyword><style  face="normal" font="default" size="100%">Reversible toxicity</style></keyword><keyword><style  face="normal" font="default" size="100%">Sleep time</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">January 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">69-74</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Objective:&lt;/strong&gt; To study the liver toxicity of &lt;em&gt;Cassytha filiformis&lt;/em&gt; L. extract and its reversibility in mice. &lt;strong&gt;Methods:&lt;/strong&gt; A total of 108 male mice were used to investigate the hepatotoxicity of &lt;em&gt;Cassytha filiformis&lt;/em&gt; extract (CFE) and the reversibility of its toxicity to the liver. Seventy-two mice were treated with CFE orally for 7 consecutive days. A half of these animals were used to study the sleep time on propofol-induced sleep that comprised the sleep onset time (SOT) and duration of sleep (DOS), while another half was used for the quantitation of serum alanine transaminase (ALT) activity. To investigate the reversibility of the liver toxicity, thirty-six mice were treated with daily CFE for 7 days. Activities of ALT and alkaline phosphatase (ALP) were determined and the liver weight ratio was measured on day 0, 1, 3 and 7 after the termination of the CFE treatment. Data of liver toxicity determination were analyzed by two-way ANOVA followed by Duncan’s multiple range test, while data of the reversibility was analyzed by Pearson’s correlation. The significance level was taken at 95% of confidence interval.&lt;strong&gt; Results:&lt;/strong&gt; CFE shortened the SOT and prolonged the DOS significantly compared with control (&lt;em&gt;p&lt;/em&gt;&amp;lt;0.05). The activity of ALT was increased due to the toxicity of CFE. However, the ALT/ALP activities decreased and liver weight ratio increased gradually after the extract treatment was discontinued. The trend of these data was correlated significantly (&lt;em&gt;p&lt;/em&gt;&amp;lt;0.05). &lt;strong&gt;Conclusion:&lt;/strong&gt; &lt;em&gt;Cassytha filiformis&lt;/em&gt; L. extract is toxic to the liver but the toxicity is reversible depending on doses.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">69</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Yori Yuliandra, Armenia Armenia*, Rahmad Arief, Mifta Hul Jannah, Helmi Arifin &lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Andalas University, INDONESIA.&lt;/p&gt;
</style></auth-address></record></records></xml>